NCT04182425

Incidence of Allergic Manifestations and Infectious Episodes in Healthy Term Infants at Risk for Dysbiosis

Real-life Study to Assess the Incidence of Allergic Manifestations and Infectious Episodes in Healthy Term Infants at Risk of Dysbiosis During the First Year of Life

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 334 (actual)
• Sponsor: Bledina · Industry
• Sex: All
• Age: 5 Weeks
• Healthy volunteers: Accepted

Summary

This study will evaluate the incidence of allergic manifestations (the first of which is atopic dermatitis) and infectious diseases in children fed with an infant formula under real conditions of use.

Detailed description

The primary objective of the study is to evaluate the cumulative incidence of atopic dermatitis in healthy infants at risk for dysbiosis at 12 months of age and to identify factors associated with the presence of atopic dermatitis.

Conditions

• Dermatitis, Allergic Contact
• Infectious Diseases

Interventions

Type	Name	Description
OTHER	Infant formula	Healthy full-term infants fed on an infant formula marketed on the French market

Timeline

• Start date: 2019-12-07
• Primary completion: 2022-07-04
• Completion: 2022-07-04
• First posted: 2019-12-02
• Last updated: 2023-03-13

Locations

1 site across 1 country: France